Abdulkader Jamal Eddin: ABO Blood Group, COVID-19 and Early Respiratory Outcomes in Acute PE
Abdulkader Jamal Eddin, Gastroenterology Resident at “Pius Brînzeu” County Emergency Clinical Hospital, Timişoara, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Cardiovascular Development and Disease, adding:
”I am pleased to share our latest publication:
‘ABO Blood Group Modifies the Association Between COVID-19 and Early Respiratory Outcomes in Acute Pulmonary Embolism’
Published in the Journal of Cardiovascular Development and Disease.
This study explores the relationship between ABO blood group, COVID-19, and early outcomes in patients with acute pulmonary embolism.
Many thanks to my co-authors and mentors for their collaboration.”
Title: Association Between ABO Blood Group, COVID-19 Status, and Early Respiratory Outcomes in Acute Pulmonary Embolism: An Interaction Analysis
Authors: Abdulkader Jamal Eddin, Stefan-Iulian Stanciugelu, Arnaldo Dario Damian, Diana Nitusca, Oana Elena Tunea, Ioana Monica Mozos
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 18, 2026, 17:48Ronak H. Mistry: Updated ASH Guidelines Bring New Focus to Iron Deficiency
-
Sep 18, 2026, 17:32Hassan Kawtharany: New Ferritin Cutoffs for the Diagnosis of Iron Deficiency With or Without Anemia
-
Sep 18, 2026, 17:20Abhishek G P: GAVE as an Important Cause of Chronic Gastrointestinal Blood Loss
-
Sep 18, 2026, 17:08Irem Karaman Sebin: ASH 2026 Changes a Key Concept in Iron Deficiency
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH